We recently identi®ed, cloned, and characterized a novel human tissue inhibitor of metalloproteinases-4, TIMP-4 (Greene et al., 1996). To determine if TIMP-4 can modulate the in vivo growth of human breast cancers, we transfected a full-length TIMP-4 cDNA into MDA-MB-435 human breast cancer cells and studied the orthotopic growth of TIMP-4-transfected (TIMP4-435) versus control (neo-435) clones in the mammary fat pad of athymic nude mice. TIMP4-435 clones expressed TIMP-4 mRNA and produced anti-metalloproteinase (MMP) activity, while neo-435 clones did not express TIMP-4 mRNA or produce detectable anti-MMP activity. Overexpression of TIMP-4 inhibited the invasion potential of the cells in the in vitro invasion assay. When injected orthotopically into nude mice, TIMP-4 transfectants were signi®cantly inhibited in tumor growth by 4 ± 10-fold in primary tumor volumes; and in an axillary lymph node and lung metastasis as compared with controls. These results suggest the therapeutic potential of TIMP-4 in treating cancer malignant progression
Introduction
The overproduction and unrestrained activity of MMPs have been linked to malignant conversion of tumor cells (Heppner et al., 1996; Himelstein et al., 1994; Bernhard et al., 1994; Pyke et al., 1993; Naylor et al., 1994; Polette et al., 1993; Urbanski et al., 1992; Tryggvason et al., 1993; Basset et al., 1990 Basset et al., , 1994 Hoyhtya et al., 1994; Poulsom et al., 1993) . The downregulation of MMPs may occur at the levels of transcriptional regulation of the genes; activation of secreted proenzymes; and through interaction with speci®c inhibitor proteins, such as TIMPs. TIMPs are secreted as multi-functional proteins that play pivotal roles in the regulation of extracellular matrix (ECM) metabolism. Their most widely recognized action is as inhibitors of matrix MMPs. Thus, the net MMP activity in the ECM is the result of the balance between activated enzyme levels and TIMP levels. Augmented MMP activity is associated with the metastatic phenotype of carcinomas, especially breast cancer Basset et al., 1990 Basset et al., , 1994 Hoyhtya et al., 1994; Poulsom et al., 1993) . Decreased production of TIMP could also result in greater eective enzyme activity and invasive potentials (Khokha et al., 1989; Denhardt et al., 1992; Mohanam et al., 1995) . These results suggest that the inhibitory activity of TIMPs might be important in inhibiting tumor malignant progression leading to invasion and metastasis, and therefore lead one to expect that an increase in the amount of TIMPs relative to MMPs could function to block tumor cell invasion and metastasis. In fact, tumor cell invasion and metastasis can be inhibited by up-regulation of TIMP expression or by an exogenous supply of TIMPs (Tsuchiya et al., 1993; Imren et al., 1996; Watanabe et al., 1996; Khokha et al., 1994; Khokha and Zimmer et al., 1992; DeClerck et al., 1992) . Alternatively, downregulation of TIMP-1 and TIMP-2 have been reported to contribute signi®cantly to the tumorigenic and invasive potentials of the cells (Khokha et al., 1989; Denhardt et al., 1992; Mohanam et al., 1995) .
In addition to inhibiting tumor cell invasion and metastasis, several previous studies have also demonstrated that TIMPs, either expressed endogenously or added exogenously, inhibit primary tumor growth of several dierent cells including c-Ha-ras transfected rat embryo ®broblasts (Imren et al., 1996) , human gastric cancer cell KKLS (Watanabe et al., 1996) , and murine B16 melanoma cells (Khokha et al., 1994) . Interestingly, both invasiveness and tumorigenic potential of murine 3T3 cells are conferred when TIMP production is impaired by an antisense approach (Khokha et al., 1989; Denhardt et al., 1992) . We have recently identi®ed and cloned a novel human tissue inhibitor of metalloproteinases, TIMP-4 (Greene et al., 1996) . In this study, we have investigated the eect of TIMP-4 on the tumorigenic, invasive, and metastatic behaviors of human breast cancer cells. We demonstrated here for the ®rst time that the in vitro invasive and in vivo tumorigenic and metastatic potentials of human breast cancer cells can also be inhibited by overexpression of a single TIMP.
Results

Transfection and selection ofTIMP-4 positive clones
In order to select a suitable breast cancer cell line for TIMP-4 gene transfection, a panel of breast cancer cell lines was screened for analysis of TIMP-4 expression. As we previously demonstrated (Greene et al., 1996) , Northern blot analysis failed to detect the TIMP-4 transcript in most breast cancer cell lines except MDA-MD-231 cells. The inability to pick up the TIMP-4 mRNA in most breast cancer cell lines by Northern blot may suggest that: (1) the TIMP-4 gene may be only expressed very weakly in breast epithelial cells but is mainly expressed in stromal cells; or (2) the expression of the TIMP-4 gene may be downregulated in breast cancers during the breast cancer malignant progression.
We selected MDA-MB-435 cell line as recipient for TIMP-4 gene transfection because: (1) it lacks detectable TIMP-4 transcript; and (2) it is relatively highly tumorigenic and metastatic in nude mice. The full-length TIMP-4 cDNA was inserted into pCI-neo mammalian expression vector. The resulting vector was transfected into MDA-MB-435 cells. The same cells were also transfected with the vector containing no insert as a control. MDA-MB-435 subclones transfected with TIMP-4 cDNA were designated TIMP4-435, and MDA-MB-435 subclones transfected with pCI-neo were designated neo-435. Clones were initially screened by in situ hybridization on slides with a speci®c TIMP-4 antisense probe (data not shown), and the positive clones were subjected to Northern blot analysis. Fifteen TIMP4-435 clones were picked up by in situ hybridization. Figure 1 shows the Northern blot analysis of TIMP-4 expression in selected clones. All four selected TIMP4-435 clones expressed TIMP-4 mRNA transcripts. In contrast, none of the parental cells or neo-435-15 clone produced any detectable TIMP-4 transcripts. No changes in morphology were observed in these clones.
Expression of MMP inhibitory activity
The anti-MMP activity of TIMP-4 transfected clones was characterized. Conditioned media (CM) from clones of , and parental MDA-MB-435 cells were collected, concentrated, and analysed for metalloproteinase inhibitory activity by soluble gelatin degradation assay (Figure 2 ). About 64% and 54% inhibition of MMP2 gelationlytic activity were observed in CMs from TIMP4-435-20 and TIMP4-435-12 clones, respectively. Whereas, CM from parental MDA-MB-435 cells only possessed 10% inhibition of MMP2 activity. A slight increase of MMP2 activity was observed in CM from neo-435-15 cells. In addition, we have previously shown that the CMs from TIMP-4-producing clones contained a prominent MMP inhibitory activity at 22 kDa in a non-reducing SDS gel containing gelatin; in contrast, no such activity was observed in the CM from neo-435 cells (Greene et al., 1996) . These data indicate: (1) the TIMP-4 positive clones secret a functional TIMP-4-mediated anti-MMP activity; (2) almost no endogenous TIMP activities were detectable in neo-435 clones in the same conditions for detection of recombinant TIMP-4 activity. Figure 3a ). In order to rule out the possibility that the dierent invasion potentials between TIMP-4 positive and TIMP-4 negative clones are due to the endogenous dierences of individual clones, we treated parental MDA-MB-435 cells with either the pooled CM from two TIMP4-435 clones or the CM from neo-435 clones. As shown in Figure 3b , when the cells were incubated with the medium containing 50% of the pooled CM from TIMP4-435 clones, cell invasion was inhibited 49%. A signi®cant 88% inhibition of invasion was observed when the cells were treated with 100% of the pooled CM from TIMP4-435 clones. In contrast, the pooled CM from neo-435 clones has no signi®cant eect on cell invasion at the same condition.
Eect of TIMP-4 transfection on tumorigenicity
To study the eect of TIMP-4 expression on tumorigenicity, we have picked three TIMP-4 positive clones: TIMP4-435-20, TIMP4-435-12 and TIMP4-435-4; and three TIMP-4 negative cells: parental MDA-MB-435, neo-435-15, and neo-435-12. Three independent experiments were done to con®rm reproducibility and the data from these experiments are summarized in Table 1 . After a lag phase of 7 ± 10 days, mice given implants of both TIMP-4 positive and TIMP-4 negative cells developed tumors. There was no dierence in tumor incidence among the groups. Control: cells were incubated in the regular DMEM-5% serum; CM (TIMP47) 50%: cells were incubated in the medium containing 50% of CM(TIMP47) plus 5% serum and 50% of regular DMEM-5% serum; CM (TIMP47) 100%: cells were incubated in the medium containing 100% of CM(TIMP47) plus 5% serum; CM(TIMP4+) 50%, cells were incubated in the medium containing 50% of CM(TIMP4+) plus 5% serum and 50% of the regular DMEM-5% serum; CM(TIMP4+) 100%: cells were incubated in the medium containing 100% of CM(TIMP4+) plus 5% serum. All values were normalized to the percent invasion of control cells which was taken as 100%. Table  1 ). After a lag phase of 15 days, tumors from parental MDA-MB-435 cells increased in volume at an exponential rate. In contrast, the growths of TIMP4-435-20 and TIMP4-435-12 cells were dramatically inhibited.
One of the TIMP-4 positive clones, TIMP4-435-4, exerted the similar tumor growth in nude mice compared with TIMP-4 negative neo-435-12 clone (experiment 3 in Table 1 ). The loss of inhibitory eect correlates with the loss of TIMP-4 expression in this clone in the in vivo environment. 
Regional and metastatic tumor dissemination
To study tumor dissemination, H&E stained paran sections of axillary lymph nodes and lungs were examined for morphologic evidence of tumor cells by light microscopy. TIMP-4 positive TIMP4-435-20 and TIMP4-435-12 clones showed an average lower proportion of lymph node positivity of 27% and 32% as compared to the average of 72% from TIMP-4 negative MDA-MB-435, neo-435-15, and neo-435-12 cells (Table 1) . TIMP-4 positive clones also yielded signi®cantly less lung micro-metastasis than TIMP-4 negative clones with a combined 16% of lung positivity for tumors as compared with a combined 40% for MDA-MB-435, neo-435-15, and neo-435-12 tumors.
Microvessel counts (MVCs) of primary tumors
The TIMP-4 negative tumors grew more rapidly and showed a higher rate of lymph node and lung metastasis than TIMP-4 positive tumors, despite a similar growth rate in vitro as compared to TIMP-4 positive cells. We performed MVC analysis in an attempt to investigate the discrepancy between these in vivo and in vitro results. Recent studies suggest that MVCs of paran sections of human breast cancers can be utilized as a measure of tumor angiogenesis, and that these MVC measurements are independent (Table 2) . Thus, using MVC as the criterion, TIMP-4 inhibited the tumor angiogenesis.
Discussion
We have overexpressed TIMP-4 in the highly malignant MDA-MB-435 human breast cancer cells, and examined the subsequent phenotypical changes on in vitro growth rates, invasive potentials, in vivo tumorigenicity, and metastasis. We showed that transfection of TIMP-4 cDNA into MDA-MB-435 cells results in a decreased rate of orthotopic tumor growth in nude mice. Tumors derived from TIMP4-435 clones also had signi®cantly lower rates of regional lymph nodes and lung metastasis. The invasive potential of MDA-MB-435 cells cross Matrigel was signi®cantly inhibited by overexpression of TIMP-4. Transfection of the MDA-MB-435 cells with a TIMP-4 cDNA leads to increased expression of the TIMP-4 transcript and anti-MMP activity when compared to parental cell line and control cells. The reduced in vitro invasiveness of TIMP4-435 clones compared to control cells suggests that the production of TIMP-4 altered the invasive potential of breast cancer cells in this experimental model system. These results are consistent with the previous reports on the inhibition of the invasion by TIMP-1 (Matsuzawa et al., 1996) and TIMP-2 (Albini et al., 1991) . While our results support a role for MMPs and their inhibitors in breast cancer cell invasion, we are aware that the Matrigel in vitro invasion assay may not be an accurate predictor of breast cancer cell invasion as it occurs in vivo. Although up-regulation of TIMP-4 in the Matrigel invasion assay clearly inhibited the in vitro invasion of MDA-MB-435 cells, the invasion process was not completely abrogated. One possible explanation for continued invasion in the presence of high levels of TIMP-4 is that more than one kind of TIMP is required to completely block the MMP activity responsible for cell invasion. Alternatively, the invasion of MDA-MB-435 cells in the Matrigel invasion assay could be mediated by some matrix degrading proteinase other than MMP.
Interaction between stromal and epithelial components in a paracrine fashion dictates the development of normal mammary gland (Lund et al., 1996; Adam et al., 1994) . In addition, the stromal component from tumor-surrounding micro-environments may also play a crucial role not only in changing the biological behavior of tumor cells but also in determining the malignant pattern of tumor cells (Paget, 1989; Berrettoni et al., 1986; Hlatky et al., 1994; Shi and Liu, 1995) . Controlled remodeling of the mammary ECM is an essential aspect in the process of normal development, and deregulated remodeling has been indicated to have a role in the etiology of breast cancer metastasis (Basset and Wolf et al., 1994; Spyratos et al., 1989; Barsky et al., 1983) . Although TIMPs were initially suggested to be important agents to suppress or prevent tumor progression leading to invasion and metastasis, recent observations have demonstrated an inhibitory eect of TIMPs on tumor growth (Tsuchiya et al., 1993; Imren et al., 1996; Watanabe et al., 1996; Khokha et al., 1994) . Within the same content, the tumorigenicity of MDA-MB-435 cells was inhibited by TIMP-4. This TIMP-4-mediated in vivo tumor growth inhibition is somewhat con¯icting to the in vitro similar growth rates of TIMP4-positive clones compared to TIMP4-negative clones. The slower in vivo growth of TIMP4-435 tumors may be explained, in part, by TIMP-4-mediated inhibition of angiogenesis. In an eort to support this hypothesis, we have measured the microvessel densities in the highly angiogenic regions of (Lamszus et al., 1997) . MCF-7 cells, which normally require estrogen supplementation for sustained in vivo tumor growth in nude mice, exhibited progressive estrogen-independent tumor growth when pro-angiogenic ®broblast growth factors (FGF-1 and FGF-4) were transfected into and overexpressed in the cells (McLeskey et al., 1993; Kern et al., 1994; Haran et al., 1994) . Our data indicate that despite the lack of growth inhibition of TIMP-4 on breast cancer cells, TIMP-4 signi®cantly inhibits tumor growth and metastasis presumably due to its antiangiogenic activity. In fact, both TIMP-1 (Johnson et al., 1994) and TIMP-2 (Ohba et al., 1995; Murphy et al., 1993) have been demonstrated to have an antiangiogenic activity, and such inhibition of angiogenesis is mediated by inhibition of both endothelial cell proliferation (Murphy et al., 1993) and migration (Johnson et al., 1994) . Although our results are consistent with the previous studies that an excessive TIMP expression could function to block the tumor growth and progression, and therefore lead one to expect that the expression of TIMPs should be down-regulated during the breast cancer malignant progression. However, both in situ hybridization and immunohistochemical staining have demonstrated TIMP-2 expression in the stroma surrounding breast carcinomas but not in benign breast tissues Poulsom et al., 1993; Visscher et al., 1994) . In particular, it was demonstrated that the clinical outcome of breast cancer is more closely related to the presence of TIMP-2 in the peri-tumoral stroma than to the corresponding MMPs (Poulsom et al., 1993) . The increased expression of TIMP-2 is usually reciprocally related to the increased expression of MMP-2 or MMP-9 Poulsom et al., 1993; Visscher et al., 1994) , suggesting that when the excess of MMP are produced during the degradation of extracellular matrix, the levels of local TIMPs expression are usually elevated. Although the elevated levels of TIMP-1 and TIMP-2 in the stroma adjunct to the invasive breast carcinomas may indicate one of the biological mechanisms to try to balance the local tissue degradation, it may represent one of the subsequent acute host responses to the remodeling stimuli but not as a causative factor. Alternatively, the high level expression of TIMP in the breast cancer may favor the proposed bi-functional molecule of both anti-proteinase activity and growth factor activity (Stetler-Stevenson et al., 1992) .
In conclusion, transfection with TIMP-4 cDNA into human breast cancer cells induces: (1) decreased invasion potential in a Matrigel invasion assay; and (2) decreased growth and lymph node and lung metastasis in the mammary fat pads of nude mice. The decreased growth rate of TIMP-4 transfected tumors may be due, in part, to inhibition of tumor angiogenesis induced by TIMP-4. Because it will be possible to design vectors that could be speci®cally targeted to tumors, the potential application of TIMP-4 as a cytostatic agent for the gene therapy treatment of cancer warrants further investigation.
Materials and methods
Tissue culture
MDA-MB-435 human breast cancer cells were obtained from the American Type Culture Collection (ATCC), Rockville, MD. Cells were cultured in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 5% (v/v) fetal calf serum, penicillin (100 U/ml), and streptomycin (100 mg/ml). Cells were subcultured weekly.
Expression of TIMP-4 in human breast cancer cells
Human TIMP-4 full-length sequence was subcloned into the pCI-neo mammalian Expression Vector (Promega) downstream of the human cytomegalovirus promoter to generate the pCITIMP4 expression vector. Forty micrograms of pCITIMP4 or the control pCI-neo plasmid were transfected into MDA-MB-435 human breast cancer cells by calcium phosphate-mediated method as we previously described (Greene et al., 1996) . Thirty G418-resistant individual clones were selected in the selection medium containing 800 mg/ml of G-418, subcloned and characterized by in situ hybridization and Northern blot analysis.
Northern blot analysis
Detection of TIMP-4 mRNA expression was analysed by Northern blot as we described previously (Greene et al., 1996) .
Preparation of conditioned media (CM)
All the clones were maintained in subcon¯uent monolayers with 5% fetal calf serum. The medium was discarded and the monolayers washed twice with phosphate-buered saline (PBS). The monolayers were cultured in the absence of serum, in DMEM supplemented with transferrin (1 mg/ L), ®bronectin (1 mg/L), and trace elements (Bio¯uides, Rockville, MD). After 24 h, the serum-free medium was discarded, and the cells were replenished with the fresh serum-free medium. The CMs were collected 30 h later. Media were then centrifuged at 1200 g and supernatants were saved and concentrated approximately ®ve-fold using an Amicon hollow ®ber concentrator with a 10 000 molecular weight cut o at 48C. The protein concentrations of CMs were determined and normalized.
Gelatin degradation assay
Inhibition of enzymatic activity by CMs from TIMP-4 transfected clones was assayed by measuring degradation of [ 3 H]gelatin in a manner conceptually similar to our previous report with some minor modi®cations. Brie¯y, tritiated type I collagen was diluted with non-radioactive type I collagen and then denatured at 558C for 10 min. Recombinant MMP2 was activated by incubation with 1 mM APMA for 20 min at 378C. The activated enzyme was pre-incubated with CMs from either TIMP-4 negative clones or TIMP-4 transfected clones for 30 min. The ®nal concentration of MMP2 was 0.4 mg/ml. These enzyme/CM mixtures were then incubated with the gelatin solution for 2 h at 378C. The reaction was stopped by addition of EDTA at a ®nal concentration of 18 mM. Proteins were precipitated on ice with 1% of trichloroacetic acid and 0.014% of tannic acid. The radioactive soluble peptide fragments were detected in a liquid scintillation counter.
In vitro assay for cell growth
Exponentially growing cultures of MDA-MB-435 clones were detached with trypsin, and the trypsin was neutralized with DMEM-5% serum. Cells were counted, diluted, and seeded in triplicate at 3000 cells per well (24-well plate) in 1 ml DMEM-5% serum. Cell growth was measured by counting cell numbers.
In vitro invasion assay
Ten-mm polycarbonate membranes were coated with 4 mg/ ml growth factor-reduced Matrigel in medium as described previously (Sheng et al., 1994) with some modi®cations. The cells were seeded at a density of 50 000 cells/ml/well in DMEM containing 5% serum. For testing the eect of CM on cell invasion, cells were incubated with either 50 : 50 medium (50% CM plus 5% serum and 50% DMEM-5% serum) or a 100% CM plus 5% serum. After incubation in a humidi®ed incubator with 5% CO 2 at 378C for 24 h, the medium as well as the cells were removed from the bottom chambers and concentrated on 3 mm polycarbonate membranes using Minifold 1 apparatus (Schleicher and Schuell). A LeukoSata Staining kit from Fisher was used to ®x and stain the cells which were counted using a Zeiss microscope.
Tumor growth in athymic nude mice
Nude mouse tumorigenic assay was performed as we previously described . Brie¯y, parental MDA-MB-435 cells, TIMP4-435 clones, and neo-435 clones were grown to 80 ± 90% of con¯uence in 150 cm 2 dishes and were harvested by incubation with 5 mM EDTA in PBS. The EDTA was neutralized with medium containing serum. The cells were washed twice with serum-free medium, counted, and re-suspended in serum-free DMEM at a concentration of 2.7610 6 cells/ml. Approximately 0.4610 6 cells (0.15 ml) were injected into 5 ± 6 week old female athymic nude mice (Frederick Cancer Research and Development Center, Frederick, MD) . Each animal received two injections, one on each side, in the mammary fat pads between the ®rst and second nipples.
The animals were ear tagged. Primary tumor growth was assessed by measuring the volume of each tumor at weekly intervals. Tumor size was determined at intervals by threedimensional measurements (mm) using a caliper. Only measurable tumors were used to calculate the mean tumor volume for each tumor cell clone at each time point. Animals were sacri®ced between 32 ± 40 days after injection, when the largest tumors reached about 15 mm in diameter.
Assessment of regional lymph node and lung metastasis
The axillary lymph nodes and lungs of sacri®ced animals were excised, ®xed in formalin, embedded in paran, and stained with hematoxylin and eosin (H&E) for microscopic examination for morphologic evidence of tumor metastasis. Sections were reviewed and scored by two pathologists (AF and MW).
Microvessel counts (MVCs) of primary tumors
Analysis of MVCs in the regions of the most angiogenic area (angiogenic`hot spots') was performed as previously described (Weidner and Semple et al., 1991; Weidner and Folkman et al., 1992) with some modi®cations (Lamszus et al., 1997) . Brie¯y, paran sections were stained with an anti-laminin antibody (Gibco, Gaithersberg, MD) (Wol et al., 1993) . Vessel pro®les were determined by counting four dierent areas of tumor containing the highest microvessel density. Two values were analysed for each tumor: (a) the peak MVC (single largest number of microvessels per 4006 ®eld); and (b) the average peak MVC (mean MVC of the 44006 ®elds with the largest numbers of microvessels). MVCs were analysed in blinded fashion.
Statistical analysis
Values were expressed as means+standard errors (s.e.s.). Comparisons were made using the two-tailed Student's ttest. Where appropriate, the chi-squared test was used to compare proportions.
